COVID-19
Vir and Alnylam Identify RNAi Therapeutic Development Candidate Targeting SARS-CoV-2
Vir Biotechnology
PR-M05-20-NI-008May 04, 2020
Coronavirus
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
WuXi Biologics
PR-M02-20-NI-033Feb 25, 2020